NeRRe Therapeutics: Funding, Investors & Team (Sep 2026)
NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.
NeRRe Therapeutics has raised $27.6M across 1 funding round on record, the most recent a Series B of $27.6M announced in Jul 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NeRRe Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2021.
NeRRe Therapeutics Funding Rounds
NeRRe Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
NeRRe Therapeutics Funding Compared to Other Biotechnology Startups
NeRRe Therapeutics' latest round of $27.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NeRRe Therapeutics in Biotechnology and Stevenage
Companies Similar to NeRRe Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
NeRRe Therapeutics Funding FAQs
What does NeRRe Therapeutics do?
NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.
How much funding has NeRRe Therapeutics raised?
NeRRe Therapeutics has raised $27.6M across 1 round on record. The most recent is a Series B of $27.6M announced in Jul 2021.
When did NeRRe Therapeutics last raise funding?
NeRRe Therapeutics' most recent funding round on record is a Series B of $27.6M, announced in Jul 2021.
Who is the CEO of NeRRe Therapeutics?
Mary Kerr is listed as CEO at NeRRe Therapeutics.
Where is NeRRe Therapeutics headquartered?
NeRRe Therapeutics is based in Stevenage, Herefordshire, United Kingdom.
How many employees does NeRRe Therapeutics have?
NeRRe Therapeutics is in the 11-50 employee band.
How does NeRRe Therapeutics' funding compare to other Biotechnology startups?
NeRRe Therapeutics' latest round of $27.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NeRRe Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeRRe Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.